Abstract:In the title compound, C14H16ClNO2, the cyclo-hexyl ring has a chair conformation. The dihedral angle between the benzene ring and the mean plane of the four planar C atoms of the cyclo-hexyl ring is 45.2 (3)°. The two carbonyl groups are trans to one another, with an O=C-C=O torsion angle of -137.1 (3)°. In the crystal, mol-ecules are linked by N-H⋯O hydrogen bonds forming chains propagating along [001]. A region of disordered electron density, situated near the unit-cell corners, was treated using the SQUEEZE routine in PLATON [Spek (2009 ▶). Acta Cryst. D65, 148-155]. It gave a solvent-accessible void of ca 400 Å(3) for only 21 electrons. It is probably due to traces of the solvent of crystallization and was not taken into account during structure refinement.

9-(4-Chloro-phen-yl)-4a-hy-droxy-4,4a,5,6,9,9a-hexa-hydro-3H-xanthene-1,8(2H,7H)-dione.

9-(2-Chlorophenyl)-4a-hydroxy-3,4,4a,5,6,7,9,9a-octahydro-2h-xanthene-1,8-dione

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Cyclopentanone 4-Nitrophenylhydrazone

9-Butyl-3,4,5,6,7,9-hexahydro-2h-xanthene-1,8-dione

Crystal Structure of 10A-Hydroxy-9-(3-nitrophenyl)-3,6-diphenyl-3,4,5,6,7,8a,9,10a-octahydro-1h-xanthene-1,8(2h)-dione

4&#946;-Hydroxy-12,13-epoxytrichothec-9-ene

2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

8-Chloromethyl-5-(2,5-dioxooxolan-3-yl)-3,3a,4,5-tetrahydro-1h-naphtho[1,2-c]furan-1,3-dione

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

1-Oxo-13c-propoxy-1,13c-dihydrodibenzo[a,kl]xanthene

9,10,11,12-Tetrachloro-12b-hydroxy-12c-phenyl-1,2,3,3a,5,6,12b,12c-octahydro-8h-cyclopenta[6,7][1,4]oxazepino[5,4-a]isoindol-8-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one